United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jul. 01, 2024

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
151 ORIC Pharmaceuticals, Inc. $518.5 M United States US Healthcare US Biotechnology
152 Applied Therapeutics, Inc. $515.3 M United States US Healthcare US Biotechnology
153 iTeos Therapeutics, Inc. $506.3 M United States US Healthcare US Biotechnology
154 Y-mAbs Therapeutics, Inc. $502.5 M United States US Healthcare US Biotechnology
155 Replimune Group, Inc. $498.1 M United States US Healthcare US Biotechnology
156 KalVista Pharmaceuticals, Inc. $497.4 M United States US Healthcare US Biotechnology
157 Akouos, Inc. $491.0 M

(Nov. 1, 2022)

 United States US Healthcare US Biotechnology
158 Cassava Sciences, Inc. $490.1 M United States US Healthcare US Biotechnology
159 Larimar Therapeutics, Inc. $484.3 M United States US Healthcare US Biotechnology
160 Annexon, Inc. $473.3 M United States US Healthcare US Biotechnology
161 Avid Bioservices, Inc. $471.8 M United States US Healthcare US Biotechnology
162 Altimmune, Inc. $471.4 M United States US Healthcare US Biotechnology
163 Esperion Therapeutics, Inc. $464.2 M United States US Healthcare US Biotechnology
164 Terns Pharmaceuticals, Inc. $459.2 M United States US Healthcare US Biotechnology
165 Vicapsys Life Sciences, Inc. $449.0 M United States US Healthcare US Biotechnology
166 Allogene Therapeutics, Inc. $443.6 M United States US Healthcare US Biotechnology
167 EyePoint Pharmaceuticals, Inc. $442.2 M United States US Healthcare US Biotechnology
168 Verve Therapeutics, Inc. $440.8 M United States US Healthcare US Biotechnology
169 Ocugen, Inc. $440.1 M United States US Healthcare US Biotechnology
170 Heron Therapeutics, Inc. $432.4 M United States US Healthcare US Biotechnology
171 Alector, Inc. $423.1 M United States US Healthcare US Biotechnology
172 Taysha Gene Therapies, Inc. $416.9 M United States US Healthcare US Biotechnology
173 Voyager Therapeutics, Inc. $409.0 M United States US Healthcare US Biotechnology
174 Concert Pharmaceuticals, Inc. $401.9 M

(June 1, 2024)

 United States US Healthcare US Biotechnology
175 Fulcrum Therapeutics, Inc. $384.7 M United States US Healthcare US Biotechnology
176 Editas Medicine, Inc. $377.5 M United States US Healthcare US Biotechnology
177 Anika Therapeutics, Inc. $374.3 M United States US Healthcare US Biotechnology
178 Gemini Therapeutics, Inc. $372.1 M United States US Healthcare US Biotechnology
179 IGM Biosciences, Inc. $370.7 M United States US Healthcare US Biotechnology
180 Lyell Immunopharma, Inc. $369.7 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2024

151. ORIC Pharmaceuticals, Inc.

Company Profile: ORIC Pharmaceuticals, Inc.
Market Cap (USD): $518.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

152. Applied Therapeutics, Inc.

Company Profile: Applied Therapeutics, Inc.
Market Cap (USD): $515.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

153. iTeos Therapeutics, Inc.

Company Profile: iTeos Therapeutics, Inc.
Market Cap (USD): $506.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

154. Y-mAbs Therapeutics, Inc.

Company Profile: Y-mAbs Therapeutics, Inc.
Market Cap (USD): $502.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

155. Replimune Group, Inc.

Company Profile: Replimune Group, Inc.
Market Cap (USD): $498.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

156. KalVista Pharmaceuticals, Inc.

Company Profile: KalVista Pharmaceuticals, Inc.
Market Cap (USD): $497.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

157. Akouos, Inc.

Company Profile: Akouos, Inc.
Market Cap (USD): $491.0 M (Nov. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

158. Cassava Sciences, Inc.

Company Profile: Cassava Sciences, Inc.
Market Cap (USD): $490.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

159. Larimar Therapeutics, Inc.

Company Profile: Larimar Therapeutics, Inc.
Market Cap (USD): $484.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

160. Annexon, Inc.

Company Profile: Annexon, Inc.
Market Cap (USD): $473.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

161. Avid Bioservices, Inc.

Company Profile: Avid Bioservices, Inc.
Market Cap (USD): $471.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

162. Altimmune, Inc.

Company Profile: Altimmune, Inc.
Market Cap (USD): $471.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

163. Esperion Therapeutics, Inc.

Company Profile: Esperion Therapeutics, Inc.
Market Cap (USD): $464.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

164. Terns Pharmaceuticals, Inc.

Company Profile: Terns Pharmaceuticals, Inc.
Market Cap (USD): $459.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

165. Vicapsys Life Sciences, Inc.

Company Profile: Vicapsys Life Sciences, Inc.
Market Cap (USD): $449.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

166. Allogene Therapeutics, Inc.

Company Profile: Allogene Therapeutics, Inc.
Market Cap (USD): $443.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

167. EyePoint Pharmaceuticals, Inc.

Company Profile: EyePoint Pharmaceuticals, Inc.
Market Cap (USD): $442.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

168. Verve Therapeutics, Inc.

Company Profile: Verve Therapeutics, Inc.
Market Cap (USD): $440.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

169. Ocugen, Inc.

Company Profile: Ocugen, Inc.
Market Cap (USD): $440.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

170. Heron Therapeutics, Inc.

Company Profile: Heron Therapeutics, Inc.
Market Cap (USD): $432.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

171. Alector, Inc.

Company Profile: Alector, Inc.
Market Cap (USD): $423.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

172. Taysha Gene Therapies, Inc.

Company Profile: Taysha Gene Therapies, Inc.
Market Cap (USD): $416.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

173. Voyager Therapeutics, Inc.

Company Profile: Voyager Therapeutics, Inc.
Market Cap (USD): $409.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

174. Concert Pharmaceuticals, Inc.

Company Profile: Concert Pharmaceuticals, Inc.
Market Cap (USD): $401.9 M (June 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

175. Fulcrum Therapeutics, Inc.

Company Profile: Fulcrum Therapeutics, Inc.
Market Cap (USD): $384.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

176. Editas Medicine, Inc.

Company Profile: Editas Medicine, Inc.
Market Cap (USD): $377.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

177. Anika Therapeutics, Inc.

Company Profile: Anika Therapeutics, Inc.
Market Cap (USD): $374.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

178. Gemini Therapeutics, Inc.

Company Profile: Gemini Therapeutics, Inc.
Market Cap (USD): $372.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

179. IGM Biosciences, Inc.

Company Profile: IGM Biosciences, Inc.
Market Cap (USD): $370.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

180. Lyell Immunopharma, Inc.

Company Profile: Lyell Immunopharma, Inc.
Market Cap (USD): $369.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch